Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) Fund Overview

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) Financial Services Profile

FSMEX is a non-diversified mutual fund concentrating at least 80% of its capital in medical technology and device companies, spanning research, development, manufacturing, and IT services for healthcare. It invests in common stocks from both domestic and international issuers, aiming to capture growth within the evolving global healthcare sector.

What Is the Investment Thesis for FSMEX?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) offers investors concentrated exposure to the medical technology and devices sector, a segment poised for long-term growth driven by an aging global population and increasing demand for advanced healthcare solutions. With a market capitalization of $3.07 billion and a Beta of 0.92, the fund exhibits a market-correlated yet slightly less volatile profile compared to the broader market. Its mandate to invest at least 80% of assets in medical technology companies, including those in R&D, manufacturing, and healthcare IT, provides direct access to innovative firms. Key value drivers include the continuous innovation cycle in medical devices, expanding global healthcare expenditures, and the adoption of new technologies. However, the fund's non-diversified nature means its performance is highly susceptible to regulatory changes, pricing pressures, and specific challenges within the healthcare industry. Investors should monitor healthcare policy developments and the performance of key portfolio holdings.

Based on FMP financials and quantitative analysis

FSMEX Key Highlights

FSMEX maintains a strict investment policy, committing a minimum of 80% of its capital to companies predominantly involved in the medical technology industry.

• The fund has a market capitalization of $3.07 billion, indicating a substantial asset base within the specialized mutual fund landscape.
• With a Beta of 0.92, FSMEX demonstrates a historical volatility profile that is slightly lower than the overall market.
• FSMEX is designated as a non-diversified fund, allowing for concentrated investments in a smaller number of securities within its specialized sector.
• The fund does not distribute dividends, indicating a focus on capital appreciation from its underlying equity holdings.

Who Are FSMEX's Competitors?

FSMEX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FSMEX's Key Strengths?

Concentrated exposure to the high-growth medical technology sector, leveraging an 80% minimum investment mandate.

• Ability to invest in both domestic and international medical technology companies, broadening the investment universe.
• Potential for significant capital appreciation driven by innovation and demographic trends in healthcare.
• Benefits from the extensive research and management resources of Fidelity Investments.

What Are FSMEX's Weaknesses?

Designation as a non-diversified fund leads to higher concentration risk in specific holdings or sub-sectors.

• Performance is highly susceptible to sector-specific downturns, regulatory changes, or pricing pressures within healthcare.
• Lack of dividend yield may not appeal to income-focused investors.
• Fund's performance is tied to the cyclicality and specific challenges of the medical device and technology market.

What Are the Key Risks for FSMEX?

**Regulatory Changes and Compliance Costs:** The medical technology industry is heavily regulated.

• New or stricter regulations from bodies like the FDA or international equivalents could increase compliance costs, delay product launches, or limit market access for FSMEX's portfolio companies, impacting their profitability.
• **Pricing Pressures and Reimbursement Challenges:** Healthcare providers and payers (governments, insurance companies) are continuously seeking to control costs. This can lead to pricing pressures on medical devices and technologies, or unfavorable changes in reimbursement policies, which could reduce revenue and profit margins for the fund's holdings.
• **Sector Concentration Risk:** As a non-diversified fund with a minimum 80% allocation to medical technology, FSMEX is highly susceptible to adverse events or downturns specific to this sector. A significant negative event affecting the medical device market could have a disproportionate impact on the fund's value compared to a diversified fund.
• **Technological Obsolescence and Competition:** The medical technology sector is characterized by rapid innovation. Companies face constant pressure to innovate, and products can quickly become obsolete. Intense competition from new entrants or established players could erode market share and profitability for FSMEX's investments.

What Are FSMEX's Competitive Advantages?

• **Specialized Sector Focus:** Deep expertise and concentrated investment in the medical technology sector, potentially allowing for more informed stock selection than generalist funds.
• **Global Reach:** Ability to invest in both domestic and international issuers provides access to a broader universe of innovative companies and diversified geographical growth opportunities.
• **Fidelity's Research Capabilities:** Benefits from the broader research and analytical resources of Fidelity Investments, a large and established asset manager.
• **Non-Diversified Structure:** While a risk, it also allows for higher conviction investments in a select number of companies, potentially leading to outperformance if those companies thrive.

What Does FSMEX Do?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) operates as a specialized mutual fund within the asset management industry, with a clearly defined investment mandate. The fund is structured to commit a minimum of 80% of its total assets to the securities of companies primarily engaged in the medical technology industry. This encompasses a broad spectrum of activities, including firms dedicated to the research, development, manufacturing, distribution, or sale of medical equipment and associated technologies. Furthermore, the fund extends its focus to companies that support drug discovery initiatives and those providing essential information technology services predominantly to healthcare providers. The investment universe for FSMEX is not limited by geography, as it actively invests in both domestic and international issuers, allowing for exposure to a global landscape of medical innovation. Its holdings largely consist of common stocks, reflecting a strategy centered on equity participation in its target companies. A critical characteristic of FSMEX is its designation as a non-diversified fund, meaning it can invest a larger proportion of its assets in a smaller number of securities, potentially leading to higher concentration risk but also higher potential returns if those concentrated investments perform well. This strategic focus positions FSMEX to capitalize on advancements and growth within the dynamic and expanding medical technology sector.

What Products and Services Does FSMEX Offer?

• Invests a minimum of 80% of its assets in companies within the medical technology industry.
• Focuses on firms involved in the research and development of medical equipment and technologies.
• Includes companies manufacturing and distributing medical devices and related products.
• Supports companies engaged in drug discovery through technological advancements.
• Invests in firms providing information technology services primarily to healthcare providers.
• Holds common stocks as its primary investment vehicle.
• Invests in both domestic and international issuers, providing global exposure.
• Operates as a non-diversified fund, allowing for concentrated investments.

How Does FSMEX Make Money?

• Generates returns through capital appreciation of its underlying equity holdings in medical technology companies.
• Aims to capitalize on growth trends within the medical technology sector by selecting companies with strong fundamentals and innovation potential.
• Collects management fees from its investors for professional portfolio management services (implied for mutual funds).
• Invests across the value chain of medical technology, from R&D to distribution and IT services.
• Leverages a non-diversified structure to potentially achieve higher returns through concentrated bets on high-conviction medical technology firms.

What Industry Does FSMEX Operate In?

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) operates within the vast and competitive asset management industry, specifically carving out a niche as a thematic fund. Its positioning is unique, focusing exclusively on the medical technology and devices sector, which is a critical sub-segment of the broader healthcare industry. This sector is characterized by rapid innovation, significant R&D investments, and a growing global demand for advanced medical solutions. FSMEX aims to capture growth from trends such as an aging global population, increasing prevalence of chronic diseases, and technological advancements in diagnostics, treatment, and digital health. While competing with broader healthcare funds and general equity funds, FSMEX differentiates itself through its concentrated, non-diversified approach to medical technology, seeking to outperform by leveraging deep sector expertise rather than broad market exposure. The fund's ability to invest both domestically and internationally further broadens its competitive scope within this specialized market.

Who Are FSMEX's Key Customers?

• Individual investors seeking specialized exposure to the medical technology sector.
• Institutional investors looking for a focused investment vehicle in healthcare innovation.
• Financial advisors recommending thematic funds to their clients.
• Retirement plans and endowments aiming for long-term growth in a specific industry.

FSMEX Financials

FSMEX Latest News

No recent news available for FSMEX.

FSMEX Analyst Consensus

FSMEX MoonshotScore

What Investors Ask About Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) — Financials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources